SI-BONE, Inc. (SIBN)
USD 13.25
(-2.57%)
USD 13.25
(-2.57%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 5.72 Million USD | -69.43% |
| 2022 | 18.71 Million USD | 181.57% |
| 2021 | -22.94 Million USD | -62.4% |
| 2020 | -14.12 Million USD | -149.07% |
| 2019 | 28.78 Million USD | 107.96% |
| 2018 | 13.84 Million USD | -15.05% |
| 2017 | 16.29 Million USD | 1055.74% |
| 2016 | 1.41 Million USD | -70.53% |
| 2015 | 4.78 Million USD | 295.42% |
| 2014 | -2.44 Million USD | -177.35% |
| 2013 | 3.16 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 6.69 Million USD | 16.97% |
| 2024 Q2 | 14.42 Million USD | 91.92% |
| 2023 Q1 | 16.89 Million USD | -9.72% |
| 2023 Q4 | 5.72 Million USD | 140.28% |
| 2023 Q3 | -14.2 Million USD | 80.06% |
| 2023 FY | 5.72 Million USD | -69.43% |
| 2023 Q2 | -71.22 Million USD | -521.54% |
| 2022 Q4 | 18.71 Million USD | 40.3% |
| 2022 Q3 | 13.33 Million USD | -14.65% |
| 2022 Q2 | 15.62 Million USD | 21.42% |
| 2022 FY | 18.71 Million USD | 181.57% |
| 2022 Q1 | 12.87 Million USD | 156.1% |
| 2021 Q4 | -22.94 Million USD | 8.02% |
| 2021 Q3 | -24.94 Million USD | -193.6% |
| 2021 Q2 | -8.49 Million USD | -489.86% |
| 2021 Q1 | 2.17 Million USD | 115.43% |
| 2021 FY | -22.94 Million USD | -62.4% |
| 2020 FY | -14.12 Million USD | -149.07% |
| 2020 Q3 | -16.62 Million USD | 38.2% |
| 2020 Q2 | -26.9 Million USD | 4.86% |
| 2020 Q1 | -28.28 Million USD | -198.24% |
| 2020 Q4 | -14.12 Million USD | 15.05% |
| 2019 Q4 | 28.78 Million USD | 8.45% |
| 2019 FY | 28.78 Million USD | 107.96% |
| 2019 Q2 | 27.59 Million USD | 4.27% |
| 2019 Q3 | 26.54 Million USD | -3.82% |
| 2019 Q1 | 26.46 Million USD | 91.19% |
| 2018 Q2 | 22.6 Million USD | 0.86% |
| 2018 Q3 | 24.89 Million USD | 10.15% |
| 2018 Q4 | 13.84 Million USD | -44.39% |
| 2018 FY | 13.84 Million USD | -15.05% |
| 2018 Q1 | 22.4 Million USD | 37.51% |
| 2017 Q4 | 16.29 Million USD | 0.0% |
| 2017 Q1 | 657 Thousand USD | 0.0% |
| 2017 Q2 | 28.73 Million USD | 4273.21% |
| 2017 FY | 16.29 Million USD | 1055.74% |
| 2016 Q1 | 20.27 Million USD | 0.0% |
| 2016 FY | 1.41 Million USD | -70.53% |
| 2015 Q1 | 4.25 Million USD | 273.86% |
| 2015 FY | 4.78 Million USD | 295.42% |
| 2014 Q4 | -2.44 Million USD | 0.0% |
| 2014 FY | -2.44 Million USD | -177.35% |
| 2013 FY | 3.16 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 78.875% |
| BrainsWay Ltd. | -10.32 Million USD | 155.436% |
| Cerus Corporation | 84.35 Million USD | 93.218% |
| Envoy Medical, Inc. | -3.81 Million USD | 250.0% |
| electroCore, Inc. | -9.95 Million USD | 157.469% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 211.629% |
| IceCure Medical Ltd | -9.93 Million USD | 157.59% |
| Inogen, Inc. | -103.56 Million USD | 105.524% |
| OrthoPediatrics Corp. | -9.26 Million USD | 161.735% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 257.127% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 143.682% |
| MaxCyte, Inc. | -27.76 Million USD | 120.607% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 211.345% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 1093.631% |
| Orthofix Medical Inc. | 96.44 Million USD | 94.068% |
| PAVmed Inc | 29.08 Million USD | 80.331% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 133.774% |
| RxSight, Inc. | -6.68 Million USD | 185.644% |
| Sight Sciences, Inc. | -102.71 Million USD | 105.57% |
| TELA Bio, Inc. | -3.94 Million USD | 244.872% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 90.019% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | -1525.284% |
| Acutus Medical, Inc. | 12.27 Million USD | 53.408% |
| Talis Biomedical Corporation | -57.06 Million USD | 110.026% |
| Spectral AI, Inc. | -3.5 Million USD | 263.41% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 111.912% |
| CVRx, Inc. | -59.95 Million USD | 109.542% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | -188.336% |
| PetVivo Holdings, Inc. | 1.27 Million USD | -347.78% |
| Bioventus Inc. | 372.51 Million USD | 98.464% |
| Venus Concept Inc. | 74.3 Million USD | 92.3% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 156.187% |
| LivaNova PLC | 62.53 Million USD | 90.851% |
| 908 Devices Inc. | -115.09 Million USD | 104.971% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 98.216% |
| Nemaura Medical Inc. | 9.92 Million USD | 42.358% |
| NeuroPace, Inc. | 54.33 Million USD | 89.471% |
| LENSAR, Inc. | -18.31 Million USD | 131.242% |
| Apyx Medical Corporation | -5.15 Million USD | 211.066% |
| Cutera, Inc. | 288.3 Million USD | 98.016% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 23.872% |
| BioSig Technologies, Inc. | 262 Thousand USD | -2083.588% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 113.053% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 162.192% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 99.593% |
| Axonics, Inc. | -77.19 Million USD | 107.411% |
| Outset Medical, Inc. | 67.67 Million USD | 91.547% |
| IRIDEX Corporation | -4.28 Million USD | 233.419% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 103.214% |
| IRadimed Corporation | -47.71 Million USD | 111.989% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 289.061% |
| INVO Bioscience, Inc. | 8.45 Million USD | 32.305% |
| Telesis Bio, Inc. | 32.63 Million USD | 82.47% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 328.645% |
| Varex Imaging Corporation | 316.9 Million USD | 98.195% |
| Quipt Home Medical Corp. | 81.73 Million USD | 93.001% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 305.643% |
| Pulmonx Corporation | -42.36 Million USD | 113.506% |
| Dynatronics Corporation | 6.2 Million USD | 7.786% |
| Modular Medical, Inc. | -8.04 Million USD | 171.139% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 233.139% |
| Semler Scientific, Inc. | -57.13 Million USD | 110.014% |
| InMode Ltd. | -135.39 Million USD | 104.225% |
| Bruker Corporation | 891.3 Million USD | 99.358% |
| Cytosorbents Corporation | 4.18 Million USD | -36.8% |
| DexCom, Inc. | 2.02 Billion USD | 99.718% |
| Align Technology, Inc. | -840.47 Million USD | 100.681% |
| Viveve Medical, Inc. | -13.81 Million USD | 141.418% |
| ZimVie Inc. | 450.41 Million USD | 98.73% |
| Movano Inc. | -5.86 Million USD | 197.528% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 104.255% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 1093.631% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | -188.336% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 98.397% |
| Profound Medical Corp. | -18.17 Million USD | 131.471% |
| Insulet Corporation | 798.1 Million USD | 99.283% |
| enVVeno Medical Corporation | -2.21 Million USD | 357.935% |
| Surmodics, Inc. | -12.01 Million USD | 147.619% |
| iCAD, Inc. | -21.2 Million USD | 126.974% |
| Nuwellis, Inc. | -2.81 Million USD | 302.944% |
| Biotricity, Inc. | 23.09 Million USD | 75.226% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 93.891% |
| Aethlon Medical, Inc. | -4.5 Million USD | 227.086% |
| InspireMD, Inc. | -8.04 Million USD | 171.112% |
| PAVmed Inc. | 29.08 Million USD | 80.331% |
| BIOLASE, Inc. | 11.34 Million USD | 49.568% |
| Beyond Air, Inc. | 6.22 Million USD | 8.155% |
| FONAR Corporation | -14.66 Million USD | 139.01% |
| AxoGen, Inc. | 32.26 Million USD | 82.269% |
| Vivani Medical, Inc. | 42 Thousand USD | -13521.429% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 153.678% |
| Inari Medical, Inc. | -7.16 Million USD | 179.891% |
| UFP Technologies, Inc. | 40.77 Million USD | 85.969% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | -86.435% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 219.904% |
| Tenon Medical, Inc. | -1.25 Million USD | 555.857% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 175.217% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 147.97% |
| AdaptHealth Corp. | 2.21 Billion USD | 99.742% |
| Sintx Technologies, Inc. | 905 Thousand USD | -532.155% |
| NanoVibronix, Inc. | -3.27 Million USD | 274.527% |
| Quanterix Corporation | -132.95 Million USD | 104.303% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 305.643% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 125.58% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 99.241% |
| TransMedics Group, Inc. | 121.13 Million USD | 95.277% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 121.853% |
| NeuroMetrix, Inc. | -1.49 Million USD | 483.684% |
| Hyperfine, Inc. | -75.61 Million USD | 107.566% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 96.241% |
| Biomerica, Inc. | -3.38 Million USD | 269.01% |
| Bone Biologics Corporation | -3.02 Million USD | 289.026% |
| AVITA Medical, Inc. | -26.23 Million USD | 121.81% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 411.193% |
| Silk Road Medical, Inc | 64.42 Million USD | 91.12% |